English | Español
Ruth de Jauregui | Jan 28, 2016

European Commission approves continued use of ambroxol, bromhexine products
Kasey Schefflin- Emrich | Jan 28, 2016

FDA approves Cosentyx as treatment for two inflammatory conditions
Carol Ostrow | Jan 28, 2016

FDA approves Bridion treatment to enhance surgical outcomes

Carol Ostrow | Jan 27, 2016

Graham Center study investigates primary care intricacies
Matt Smith | Jan 26, 2016

First PSA campaign for prediabetes set to launch
Matt Smith | Jan 26, 2016

ALS Research Program announces FY2015 award recipients
Matt Smith | Jan 26, 2016

MD Anderson Cancer Center to collaborate with Abbvie on cancer research
Matt Smith | Jan 26, 2016

Smiles for Life app aids family physicians diagnosing oral issues

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’